Advent International announces the completion of the acquision of Suven Pharma

New Board of Directors and management team at Suven Pharma also appointed

Menarini strengthens its presence in aesthetic dermatology in India

The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation

Briefs: Sun Pharmaceutical Industries and Dr. Reddy’s

Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.

Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals

The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company

Doceree raises US$ 35 million in Series B Funding

Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe

Lupin's Joint Airways Initiative surpasses 10,000 patients

USFDA inspection at Piramal Pharma’s Bethlehem facility

Apollo Hospitals acquires partly built hospital in Sonarpur, Kolkata

The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months

Alkem rolls out patient awareness drive under its breathe initiative

Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India

Cosmo and Glenmark sign distribution and license agreements for Winlevi in Europe and South Africa

Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries